KMPH - Zevra Therapeutics Inc
Previous close
5.46
0 0%
Share volume: 0
Last Updated: Wed 01 Mar 2023 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$5.46
0.00
0.00%
Summary score
38%
Profitability
45%
Dept financing
25%
Liquidity
8%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
16.84%
Return on assets
-26.86%
Return on sales
-108.86%
Return on invested capital
41.31%
Total debt ratio
450.25%
Debt ratio change over timeo
-28.43%
Current Ratio
3.48%
Quick Ratio
0%
Cash Position Ratio
1.01%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
4.99%
Return on assets
-18.56%
Return on sales
-154.56%
Return on invested capital
203.23%
Total debt ratio
736.94%
Debt ratio change over timeo
-118.61%
Current Ratio
0.35%
Quick Ratio
0%
Cash Position Ratio
0.2%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
4.83%
Return on assets
-10.83%
Return on sales
0%
Return on invested capital
4.44%
Total debt ratio
656.29%
Debt ratio change over time
-530.36%
Current Ratio
0.12%
Quick Ratio
0%
Cash Position Ratio
0.07%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-130.17%
Return on assets
-40.09%
Return on sales
202.9%
Return on invested capital
-139.78%
Total debt ratio
-2842.63%
Debt ratio change over time
-28.43%
Current Ratio
-3.45%
Quick Ratio
0%
Cash Position Ratio
-1.59%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KMPH | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 16.84% | 0% | 0% | 26.83% |
| Return on assets | -26.86% | 0% | 0% | -10.24% |
| Return on sales | -108.86% | 0% | 0% | -1670.47% |
| Return on invested capital | 41.31% | 0% | 0% | 57.71% |
| Profitability | 34% | 0% | 50% | 50% |
| Total debt ratio | 450.25% | 0% | 0% | 168.24% |
| Debt ratio change over time | -28.43% | 0% | 0% | 17.84% |
| Dept financing | 25% | 0% | 0% | 34% |
| Current Ratio | 0.35% | 0% | 0% | 8.32% |
| Quick Ratio | 0% | 0% | 0% | 8.32% |
| Cash Position Ratio | 0.2% | 0% | 0% | 7.97% |
| Liquididy | 24% | 0% | 0% | 75% |
| Short-term ratios | KMPH | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 4.99% | 0% | 0% | -39.65% |
| Return on assets | -18.56% | 0% | 0% | -13.45% |
| Return on sales | -154.56% | 0% | 0% | -4352.39% |
| Return on invested capital | 203.23% | 0% | 0% | 120.66% |
| Profitability | 50% | 0% | 50% | 15% |
| Total debt ratio | 736.94% | 0% | 0% | 65.53% |
| Debt ratio change over time | -118.61% | 0% | 0% | 0.08% |
| Dept financing | 25% | 0% | 0% | 27% |
| Current Ratio | 0.35% | 0% | 0% | 8.32% |
| Quick Ratio | 0% | 0% | 0% | 8.32% |
| Cash Position Ratio | 0.2% | 0% | 0% | 7.97% |
| Liquididy | 2% | 0% | 0% | 75% |